Although de novo USP7 germline mutations have been found to cause neurological disorders by disrupting its regulation of MAGE-L2-TRIM2710, USP7 is best known to regulate the MDM2-TP53 axis via deubiquitination11, affecting several downstream pathophysiological processes such as DNA repair, immune response, and cancer. This evidence concerns the gene USP7 and cancer.